ICD-10-CM Billable Code

L49.1

Exfoliation due to erythematous condition involving 10-19 percent of body surface

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code L49.1 refers to a skin condition characterized by exfoliation, or peeling, caused by an erythematous (red and inflamed) skin condition affecting between 10 to 19 percent of the body surface area. This condition indicates a moderate level of skin involvement and often results from underlying inflammatory skin disorders. Recognizing this condition can help in understanding its impact on health and the importance of appropriate management.

Causes & Symptoms

Clinical Causes: Severe dermatitis or eczema Drug reactions, such as allergic or adverse responses to medications Infections leading to skin inflammation Autoimmune skin disorders like psoriasis Other inflammatory skin diseases Environmental factors causing skin irritation Underlying systemic illnesses with skin manifestations

Key Symptoms: Extensive redness and inflammation of the skin Peeling or exfoliation of large skin areas, specifically affecting 10-19% of the body surface Skin discomfort such as itching or burning sensations Possible swelling or blistering in affected regions Presence of skin soreness or tenderness In some cases, systemic symptoms like fever or malaise if an infection or systemic illness is involved

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a clinical examination where a healthcare provider assesses skin appearance and extent of involvement. Medical history may include recent medication use, infections, or underlying health conditions. Sometimes, skin biopsy or laboratory tests are performed to identify the underlying cause of the erythematous skin reaction and exfoliation. The percentage of body surface area involved is estimated to determine severity and guide treatment planning.

Treatment Protocols: Management focuses on addressing the underlying cause and alleviating symptoms. Common approaches include: - Use of topical corticosteroids or anti-inflammatory agents to reduce inflammation - Moisturizing to support skin barrier repair and reduce peeling - Discontinuation of any offending medications if applicable - Systemic treatments such as corticosteroids or immunosuppressants in severe cases - Treating any accompanying infections with appropriate antimicrobial therapy - Supportive care, including pain relief and skin protection measures Regular follow-up with healthcare providers is essential to monitor progress and adjust treatment as needed.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is L49.1 a billable ICD-10 code?
Yes, L49.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report L49.1?
Clinical documentation must specify the nature of Exfoliation due to erythematous condition involving 10-19 percent of body surface and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

erythematous percent exfoliation condition surface